Alprazolam pharmacology
Pro Research Analysisby 
Searched over 200M research papers for "alprazolam pharmacology"
Alprazolam Structure and Absorption Pharmacology
Alprazolam is a triazolobenzodiazepine, meaning it is a benzodiazepine with a triazolo ring added to its structure, which distinguishes it from other drugs in its class 13. After oral administration, more than 90% of alprazolam is absorbed, and the absorption rate does not depend on the dose 14. Peak plasma concentrations are typically reached within 0.7 to 2.1 hours after taking a dose 134. The drug is fully available after oral administration, and its pharmacokinetic parameters are not significantly affected by the route of administration .
Distribution, Metabolism, and Elimination
Alprazolam has a volume of distribution of about 0.7–0.8 L/kg and an elimination half-life of approximately 12 to 15 hours 34. It is metabolized mainly by the cytochrome P450 3A subfamily in the liver, producing metabolites such as 4-hydroxyalprazolam (less active) and α-hydroxyalprazolam (more active) . Interestingly, the brain also metabolizes alprazolam, producing higher amounts of the more active α-hydroxyalprazolam, which may prolong its effects in the brain . Factors like liver and kidney disease, smoking, age, sex, and obesity have minimal impact on alprazolam’s pharmacokinetics .
Drug Interactions and Double-Peak Phenomenon
Alprazolam has few clinically significant drug interactions, but cimetidine and oral contraceptives can reduce its clearance and increase its half-life . In some cases, a double-peak phenomenon in plasma concentration has been observed after oral administration, likely due to delayed absorption caused by alprazolam’s muscle relaxant effect on gastric motility . This effect is unique among benzodiazepines and may have implications for drug interactions and therapeutic outcomes .
Mechanism of Action and Central Nervous System Effects
Alprazolam acts primarily by enhancing the effect of gamma-aminobutyric acid (GABA) at the GABA_A receptor, leading to anxiolytic, sedative, and muscle relaxant effects 135. It is unique among benzodiazepines for its ability to suppress corticotropin-releasing hormone (CRH) neurons, which may explain its effectiveness in both anxiety and depressive disorders . Alprazolam also produces dose-dependent changes in EEG activity, increasing central beta and occipital delta power, which are associated with anxiolysis and sedation, respectively .
Clinical Efficacy and Therapeutic Uses
Alprazolam is effective for treating generalized anxiety disorder, panic attacks (with or without agoraphobia), and symptoms of depression 23. It provides rapid symptom relief, often within the first week of treatment . Studies show it is as effective as other benzodiazepines and tricyclic antidepressants for anxiety and panic disorders, but selective serotonin reuptake inhibitors (SSRIs) are generally preferred as first-line treatments . Alprazolam is also being explored for use in other conditions, such as schizophrenia, premenstrual syndrome, and as a cardioprotective agent .
Adverse Effects, Dependence, and Withdrawal
The most common side effect of alprazolam is mild sedation, especially early in treatment 123. It can impair cognitive and psychomotor performance, which is important for patients who drive or operate machinery 24. While the risk of dependence and abuse is similar to other benzodiazepines, withdrawal and rebound symptoms are common if the drug is stopped abruptly, so discontinuation should be gradual 23.
Alternative Routes of Administration
Intranasal administration of alprazolam has been studied as a way to achieve faster onset of action compared to oral dosing. This route leads to higher plasma and brain concentrations shortly after administration, shortens sleep latency, and prolongs sleep duration, suggesting potential benefits for rapid symptom relief .
Conclusion
Alprazolam is a fast-acting triazolobenzodiazepine with high oral bioavailability, a moderate half-life, and a pharmacological profile similar to other benzodiazepines but with unique features, such as suppression of CRH neurons and a double-peak absorption phenomenon. It is effective for anxiety and panic disorders, but care must be taken with its sedative effects, potential for dependence, and withdrawal symptoms. New delivery methods, like intranasal administration, may offer faster relief for certain conditions.
Sources and full results
Most relevant research papers on this topic